On Monday, home health company Amedisys announced it had accepted a $101 per share, all-cash offer from UnitedHealth Group’s Optum. Analysts expect the Federal Trade Commission to scrutinize the proposed $3.3 billion deal between UnitedHealth Group’s Optum and the home health company, Modern Healthcare reports.
Optum’s offer outbid rival Optioncare Health, which had offerd $97.38 a share. Option Care said it was “disappointed” with the cancellation of the deal and is due to receive $106 million from Amedisys as per its May agreement. Read more.
